Join

Compare · PRKS vs VRAY

PRKS vs VRAY

Side-by-side comparison of United Parks & Resorts Inc. (PRKS) and ViewRay Inc. (VRAY): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both PRKS and VRAY operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • PRKS is the larger of the two at $2.14B, about 2.9x VRAY ($726.7M).
  • PRKS has hit the wire 2 times in the past 4 weeks while VRAY has been quiet.
  • VRAY has more recent analyst coverage (9 ratings vs 8 for PRKS).
MetricPRKSVRAY
Company
United Parks & Resorts Inc.
ViewRay Inc.
Price
-
-
Market cap
$2.14B
$726.7M
1M return
-
-
1Y return
-
-
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NYSE
NASDAQ
IPO
2013
News (4w)
2
0
Recent ratings
8
9
VRAY

ViewRay Inc.

ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Latest PRKS

Latest VRAY